Sanofi
SNYNASDAQHealthcare● Active
$44.16
$-0.86(-1.91%)
Market Cap$106.4B
P/E Ratio—
52W High$52.68
52W Low$42.28
Sanofi（SNY）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · SNY · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $46.72B | $44.29B | $41.62B | $40.56B | $39.17B |
| Cost of Revenue | $13.05B | $13.21B | $12.63B | $11.88B | $12.26B |
| Gross Profit | $33.67B | $31.08B | $28.99B | $28.68B | $26.92B |
| Gross Margin %(computed) | 72.07% | 70.18% | 69.66% | 70.71% | 68.72% |
| Operating Expenses | |||||
| R&D Expenses | $7.84B | $7.39B | $6.51B | $6.50B | $5.69B |
| G&A Expenses | $9.54B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $24.07B | $23.83B | $22.03B | $18.52B | $18.79B |
| Operating Income | $9.60B | $7.25B | $6.96B | $10.16B | $8.13B |
| Operating Margin %(computed) | 20.54% | 16.38% | 16.72% | 25.05% | 20.74% |
| Interest Income | $0.33B | $0.46B | $0.53B | $0.17B | $0.00B |
| Interest Expense | $0.63B | $0.62B | $0.51B | $0.38B | $0.38B |
| Income Before Tax | $6.02B | $6.76B | $6.12B | $9.99B | $7.84B |
| Income Tax Expense | $1.04B | $1.20B | $1.02B | $1.91B | $1.56B |
| Net Income | $7.81B | $5.56B | $5.40B | $8.37B | $6.22B |
| Net Margin %(computed) | 16.72% | 12.55% | 12.98% | 20.64% | 15.89% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $3.20 | $2.19 | $2.15 | $3.19 | $2.49 |
| Wtd Avg Shares | 2.44B | 2.50B | 2.50B | 2.50B | 2.50B |
| EBITDA | $12.48B | $11.03B | $11.39B | $13.51B | $11.54B |
| EBITDA Margin %(computed) | 26.71% | 24.91% | 27.37% | 33.31% | 29.45% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · EUR · B
深入了解Sanofi
关于Sanofi（SNY）损益表
Sanofi（SNY）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，SNY实现营收$46.72B，毛利润$33.67B（毛利率72.07%），净利润$7.81B（净利率16.72%）。
常见问题
SNY · 4 问Sanofi（SNY）2025财年营收为$46.72B，同比up5.5%。
SNY revenueSNY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08